Approval is for limited use in hospitals for ICU use for COVID patients and for expectant moms fearing gestational diabetes; also, Google's Verily grabbed a few billion of Dx shares and Verily's CFO (Deepak A) is pressuring Dx to keep up the share price with 'managed release' of G7 info into the public domain - this is a common trick used by tech companies with no revenues to boost their stock price .
Also, Verily is a big investor in Dx and is preparing for an IPO of their own - so leaking positive info is a clever (but unethical/illegal) way to shore up Dx stock price
